MDM2 mutation	Breast Cancer	MDM2 mutation	Breast Cancer	ribociclib Sensitive: B - Late Trials ribociclib Sensitive : B	ribociclib Sensitive: B - Late Trials ribociclib Sensitive : B
MDM2 mutation	Non Small Cell Lung Cancer	MDM2 mutation	Non Small Cell Lung Cancer	cetuximab + avelumab Sensitive: C3 – Early Trials cetuximab + avelumab Sensitive : C3	cetuximab + avelumab Sensitive: C3 – Early Trials cetuximab + avelumab Sensitive : C3
MDM2 mutation	Non Small Cell Lung Cancer	MDM2 mutation	Non Small Cell Lung Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3

MDM2 mutation

Associations